Description
Talented and innovative researcher with a proven track record in both industry and academic labs. I started working for a biotech company, FibroGen Inc., researching and developing drugs for human diseases. My work helped lead to the FDA’s approval for IND of drugs now in clinical trials for pulmonary fibrosis, pancreatic cancer, and anemia. I then earned my Ph.D. in pharmacology studying the role of AKAP5 in the cAMP/PKA signaling pathway in cardiomyocytes (fight or flight response). I am currently studying the role of protein kinase D signaling in cardiomyocytes, including PKD in inflammation. I utilize molecular biology to clone fluorescence tagged proteins and utilizing state of the art microscopy techniques to study signal transduction pathways in living cells and tissues. I plan to pursue my career in science with a focus in Pharmacology. I enjoy mentoring others and leading a group project to completion. At Fibrogen, I demonstrated my potential to be a productive and successful lead research investigator within my group in developing new drugs and helping to earn the FDA’s IND status. I greatly enjoy the fast pace and multitasking that small Biotech companies offer. The drugs we developed are now in phase II/III clinical studies. My extensive experience attests to my potential as a candidate for the challenging positions I am seeking.
Accomplishments
Highlights:
Keywords
